[GSK] YoY Quarter Result on 31-Dec-2016 [#Q4]

Announcement Date
30-Dec-2016
Financial Year
2016
Quarter
31-Dec-2016 [#Q4]
Profit Trend
QoQ- -68.19%
YoY- 172.60%
Quarter Report
View:
Show?
Quarter Result
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
Revenue 8,899,000 8,197,000 7,639,000 7,586,000 6,286,000 6,186,000 6,906,000 4.31%
PBT 1,711,000 1,374,000 442,000 423,000 -416,000 531,000 2,546,000 -6.40%
Tax 194,000 74,000 805,000 106,000 12,000 -494,000 41,000 29.55%
NP 1,299,000 1,215,000 -546,000 257,000 -354,000 1,033,000 2,461,000 -10.09%
Tax Rate -11.34% -5.39% -182.13% -25.06% - 93.03% -1.61% -
Total Cost 7,600,000 6,982,000 8,185,000 7,329,000 6,640,000 5,153,000 4,445,000 9.34%
Ratio Analysis
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
NP Margin 14.60 14.82 -7.15 3.39 -5.63 16.70 35.64 -13.81%
Per Share
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
EPS 0.33 0.31 -0.14 0.07 -0.09 0.27 0.64 -10.44%
EPS Diluted 0.32 0.31 -0.14 0.07 -0.09 0.27 0.63 -10.67%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ & YoY figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.